GSK added Ojjaara to its portfolio through the acquisition of Sierra in 2022. Credit: Magda Wygralak via Shutterstock. Health ...

Syros noted that SELCT-MDS-1 Phase III trial’s failure to meet its endpoint constituted a default event under its secured ...

The AUGMENT-101 trial evaluated the safety and efficacy of revumenib in adults with relapsed or refractory mutant NPM1 AML.

Though prescribing climate-friendly dry powder inhalers is environmentally sound, some experts warn certain patients may be ...

The US Food and Drug Administration (FDA) has awarded the second breakthrough therapy designation (BTD) to Johnson & ...

NHS England states that the tablet is as effective as vapes in helping people stop smoking, and even better than ...

Lyophilization is a practical and essential process for the production of biologics and other sensitive compounds. Image ...

Ontada has entered into a strategic partnership with health data platform Datavant to enable quick access to oncology ...

Intercept’s US president Vivek Devaraj said the pharma company still believes in the evidence supporting the liver disease ...

The unit was established following Pfizer’s acquisition of Hospira in 2015. Credit: Pfizer. Pfizer is currently assessing the ...

Zai Lab and argenx have announced receipt of approval from the National Medical Products Administration (NMPA) of China for ...

Autolus’ Aucatzyl is a B-lymphocyte antigen CD19 CAR-T cell therapy. Credit: NDAB Creativity via Shutterstock. Autolus ...